Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,940 public trials 1,514 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

An Evaluation of the Usability and Usefulness of a Multi-language Online Patient Education Module

NCT01248676

Conditions: Cancer, Neoplasms
Locations: Odette Cancer Centre at Sunnybrook Health Sciences Toronto, Ontario, Canada

View Trial Details

Completed

Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes

NCT00393029

Conditions: Adenocarcinoma, Anti-p53 TCR-Gene, Carcinoma, +18 more
Locations: National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Completed

PEACH Trial: Prescribed Exercise After Chemotherapy

NCT01030887

Conditions: Behavior, Cancer, Motor Activity, +1 more
Locations: Medical Oncology Department, St. James's Hospital Dublin, Ireland

View Trial Details

Completed

Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma

NCT00073736

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: University of California at Irvine Orange, California, United States

Prince of Wales Hospital - Comprehensive Cancer Trial Unit Shatin, New Territories, Hong Kong

Tri-Services General Hospital Taipei, Nei Hu District, Taiwan

Chang-Gung Memorial Hospital Taipei, Taoyuan County, Taiwan

View Trial Details

Completed

A Trial Of SU14813 In Patients With Advanced Solid Malignancies

NCT00982267

Conditions: Neoplasms, Solid Tumors
Locations: Pfizer Investigational Site Hamburg, Germany

Pfizer Investigational Site Amsterdam, Netherlands

View Trial Details

Completed

Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

NCT00429559

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: University Hospital of Crete Heraklion, Crete, Greece

University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece

"IASO" General Hospital of Athnes, Dep of Medical Oncology Athens, Greece

"Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece

View Trial Details

Completed

XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

NCT00882869

Conditions: Advanced Hepatocellular Carcinoma, Neoplasms
Locations: Tuen Mun Hospital Tuenmen, New Territories, Hong Kong, China

Queen Elizabeth Hospital Hong Kong, China

Queen Mary Hospital Hong Kong, China

View Trial Details

Completed

Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT01378416

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

NCT00165451

Conditions: Neoplasms
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Phase II Trial of Allovectin-7® for Metastatic Melanoma

NCT00044356

Conditions: Malignant Melanoma, Melanoma, Metastatic Melanoma, +16 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

University of Arkansas Cancer Research Center Little Rock, Arkansas, United States

Comprehensive Blood and Cancer Center Bakersfield, California, United States

University of California, San Francisco San Francisco, California, United States

View all 16 locations

View Trial Details